CA2760688A1 — Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
Assigned to Atley Pharmaceuticals Inc · Expires 2010-11-04 · 16y expired
What this patent protects
The invention provides oral formulations for the treatment of cold and allergy symptoms. Each formulation com-bines an antihistamine, an antitussive, and/or a decongestant into one extended release composition. The invention further pro-vides for methods of making and using such …
USPTO Abstract
The invention provides oral formulations for the treatment of cold and allergy symptoms. Each formulation com-bines an antihistamine, an antitussive, and/or a decongestant into one extended release composition. The invention further pro-vides for methods of making and using such formulations, as well as for methods for preventing abuse or extraction of a single drug present in an oral extended release composition comprising two or more of an antihistamine, antitussive, and/or deconges-tant.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.